Skip to content
Search

Latest Stories

Pharmacy bodies look forward to working with Steve Barclay again

Leading pharmacy bodies and associations are looking forward to working with 'reappointed' Secretary of State for Health and Social Care, Steve Barclay, on ‘future roles’ and ‘funding’ for the community pharmacy.

The Royal Pharmaceutical Society (RPS) England Country Board Chair, Thorrun Govind, hopes that the ministers will now be able to focus on addressing the key challenges facing the health service and the country.


“This means not just getting through the winter, but planning for and investing in the future.”

She added: “It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost of long-term conditions, and deliver best value from medicines.

Govind urged the minister "to support a more ambitious approach to advancing the clinical role of pharmacists across the NHS, including through a ‘Pharmacy First’ approach in England.”

“Amid warnings of potential cuts to public spending, I hope the Government listens to health and care leaders who are united in the need for a comprehensive workforce plan to deliver better patient care. This must include investment in pharmacy education and training.”

“As scientists and researchers, as well as clinicians, pharmacists also play a key role in pharmaceutical industry and will be vital to building on the UK’s position as a world leader in new therapies and technologies.”

On the reappointment of Steve Barclay to his former post of Secretary of State  for Health and Social Care, Dr Leyla Hannbeck, Chief Executive, Association of Independent Multiple Pharmacies (AIMp) said: “It is hoped the return of his brief will recognise the growing calls for community pharmacy in primary care and the wider NHS.”

“The network, it’s trust, respect and convenience for patients give the Secretary of State  a resounding platform to enhance our role by meeting many of the ambitions of the long term plan. We welcome the opportunities which now lay ahead to demonstrate how community pharmacy can play an integrated role in patient focused healthcare and population health.“

The National Pharmacy Association (NPA) looks forward to working constructively with Steve Barclay and his team, “aiming to secure the kind of support that will enable its members to help get the NHS back on its feet.”

NPA Chief Executive Mark Lyonette said: “The same logic that led all recent Health Secretaries to talk about a ‘pharmacy first’ approach to primary care still applies today. That provides a basis for a serious conversation about investment, even though all parts of government have been asked to look for cost savings.

“We want him to buy into our can-do agenda for urgent care, long-term conditions, medicines optimisation and prevention.”

The Company Chemists Association (CCA)’s spokesperson commented: “Mr Barclay rebegins his role at a crucial time for the pharmacy sector. The Secretary of State will find that community pharmacies are invariably solutions providers and can take positive steps forward to relieve pressures across the sector.

"We are encouraged that the Health Secretary previously worked on a ‘Pharmacy First’ model, however pharmacies need immediate investment for this plan to be realised.

“A real-term cut in funding spanning eight years is having a deeply concerning impact on the sector’s ability to care for patients.”

Citing the data from its recent research, CCA said, “permanent closures are happening at a concerning rate in areas of deprivation, with 41% of permanent closures since 2015 occurring in the 20% most deprived areas of England. It is only with investment that community pharmacy’s full potential can be realised so it can deliver more for patients and ensure the best value for taxpayers.”

During his previous tenure, we successfully concluded negotiations for year 4 and 5 of the CPCF and we were very grateful to him for all his efforts during this process, said the Pharmaceutical Services Negotiating Commitee (PSNC) Chief Executive Janet Morrison.

"He re-joins the Department at a crucial time for community pharmacy as we continue to experience unsustainable and damaging pressures, due to chronic underfunding of the sector.

"We look forward to working with Mr Barclay, the Pharmacy Minister and their colleagues to further dialogue about the future role and funding of community pharmacy.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less